Ultrasound-guided “sonobiopsy” for new brain tumor diagnosis
Treatments studied
Part of Cancer clinical trials.
This trial tests a new way to take a tiny tissue sample from a suspected glioblastoma using ultrasound, to improve noninvasive detection. You may be able to get this targeted sample while you’re already planning surgery for tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old with a newly found brain lesion or confirmed recurrent tumor
- Your most recent brain MRI was within the last 28 days (and shows features of glioblastoma, or confirmed recurrence)
- The tumor/lesion is over 3 cm and is located in the upper part of the brain (supratentorial) within 5 cm of the brain surface
- The lesion shows gadolinium enhancement on MRI (it “lights up” after contrast dye)
- You are planning to have surgical resection (or, for recurrence, laser ablation) of the tumor
- You can safely have an MRI, and you don’t have certain scalp/skull issues or implanted materials that interfere with the ultrasound probe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a new imaging method to help doctors see brain tumors more clearly before surgery. It may help remove the tumor more safely and completely.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This trial tests a new way of treating recurrent glioblastoma that has a specific genetic feature called mismatch repair deficiency. It uses focused ultrasound to help the immunotherapy drug pembrolizumab work better against the tumor.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.